FR2355849B1 - - Google Patents

Info

Publication number
FR2355849B1
FR2355849B1 FR7725559A FR7725559A FR2355849B1 FR 2355849 B1 FR2355849 B1 FR 2355849B1 FR 7725559 A FR7725559 A FR 7725559A FR 7725559 A FR7725559 A FR 7725559A FR 2355849 B1 FR2355849 B1 FR 2355849B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7725559A
Other languages
French (fr)
Other versions
FR2355849A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Glaxo Wellcome SA
Glaxo Laboratories Ltd
Original Assignee
Laboratoires Glaxo SA
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Glaxo SA, Glaxo Laboratories Ltd filed Critical Laboratoires Glaxo SA
Publication of FR2355849A1 publication Critical patent/FR2355849A1/fr
Application granted granted Critical
Publication of FR2355849B1 publication Critical patent/FR2355849B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7725559A 1973-12-21 1977-08-22 Derives de l'acide 7 b-acylamidoceph-3-eme 4-carboxyliques, leur procede de preparation et application therapeutique Granted FR2355849A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB59517/73A GB1496757A (en) 1973-12-21 1973-12-21 Cephalosporin derivatives

Publications (2)

Publication Number Publication Date
FR2355849A1 FR2355849A1 (fr) 1978-01-20
FR2355849B1 true FR2355849B1 (sv) 1980-10-17

Family

ID=10483908

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7725559A Granted FR2355849A1 (fr) 1973-12-21 1977-08-22 Derives de l'acide 7 b-acylamidoceph-3-eme 4-carboxyliques, leur procede de preparation et application therapeutique

Country Status (8)

Country Link
JP (1) JPS5655392A (sv)
BE (1) BE823651A (sv)
CA (1) CA1059991A (sv)
CH (1) CH626370A5 (sv)
FR (1) FR2355849A1 (sv)
GB (1) GB1496757A (sv)
PH (1) PH11646A (sv)
ZA (1) ZA748146B (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE432254B (sv) * 1975-02-04 1984-03-26 Fujisawa Pharmaceutical Co Analogiforfarande for framstellning av 3-substituerade 7-(alfa,alfa-disubstituerade acetamido)-3-cefem-4-karboxylsyror
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
US4284631A (en) * 1978-07-31 1981-08-18 Fujisawa Pharmaceutical Co., Ltd. 7-Substituted cephem compounds and pharmaceutical antibacterial compositions containing them
IT1126819B (it) * 1978-10-27 1986-05-21 Glaxo Group Ltd Antibiotici cefalosporinici,composizioni che li contengono e procedimento per produrli
IL58717A (en) * 1978-11-15 1983-05-15 Glaxo Group Ltd Derivatives of(6r,7r)-7-((z)-2-(2-aminothiazol-4-yl)-2-(carboxy-(lower alkyl or cycloalkyl)oxyimino)acetamido)-3-(2-alkyl-pyrazolium-1-ylmethyl)ceph-3-em-4-carboxylate,process for their preparation and pharmaceutical compositions comprising them
ZA877987B (en) * 1986-11-12 1988-08-31 Ici Pharma Antibiotic compounds
EP0272827A3 (en) * 1986-12-23 1990-02-07 ZENECA Pharma S.A. 3-heterocyclicthiomethyl cephalosphorins
US5262410A (en) * 1986-12-23 1993-11-16 Ici Pharma 3-heterocyclic thiomethyl cephalosporins
US20040166434A1 (en) 2003-02-21 2004-08-26 Dammel Ralph R. Photoresist composition for deep ultraviolet lithography
CA2932121A1 (en) 2007-11-30 2009-06-11 Newlink Genetics Corporation Ido inhibitors

Also Published As

Publication number Publication date
BE823651A (fr) 1975-06-20
FR2355849A1 (fr) 1978-01-20
GB1496757A (en) 1978-01-05
CA1059991A (en) 1979-08-07
ZA748146B (en) 1976-01-28
PH11646A (en) 1978-05-08
CH626370A5 (en) 1981-11-13
JPS5655392A (en) 1981-05-15

Similar Documents

Publication Publication Date Title
AR201758A1 (sv)
AU476761B2 (sv)
AU465372B2 (sv)
AR201235Q (sv)
AR201231Q (sv)
AU474593B2 (sv)
AU474511B2 (sv)
AU474838B2 (sv)
AU471343B2 (sv)
AU465453B2 (sv)
AU465434B2 (sv)
AU450229B2 (sv)
AU476714B2 (sv)
AR201229Q (sv)
AU466283B2 (sv)
AU476696B2 (sv)
AU472848B2 (sv)
AR199451A1 (sv)
AU477823B2 (sv)
AR197627A1 (sv)
AU471461B2 (sv)
AR200256A1 (sv)
AU461342B2 (sv)
AR210729A1 (sv)
AR195311A1 (sv)

Legal Events

Date Code Title Description
ST Notification of lapse